2024-06-05 13:31:03 ET
Agilent Technologies, Inc. (A)
Jefferies 2024 Global Healthcare Conference
June 5, 2024, 08:30 AM ET
Company Participants
Robert McMahon - Senior Vice President and Chief Financial Officer
Conference Call Participants
Tycho Peterson - Jefferies
Presentation
Tycho Peterson
All right, we're good to go. Good morning, everyone. I'm a Tycho Peterson from the life science team here at Jefferies. Pleased to introduce Bob McMahon from Agilent.
Robert McMahon
Great, thanks. Thanks, Michael. Good to see you. Great to be here, and good to see you in the saddle.
Tycho Peterson
Thank you. Two old men wearing glasses. We're getting old. Let's talk about 2Q. Why don't we start there? And just as you're kind of thinking about things going forward, obviously, a lot of headwinds – NASD, pharma instruments, China. Maybe just kind of talk through each of those dynamics and how we should be kind of thinking about the next couple of quarters.
Robert McMahon
Yeah, yeah. So, our Q2, we actually met expectations. Revenue was down about 7%, right in the midpoint of our guidance and actually had leverage on the bottom line, declined about 4%, exceeding our expectations. And as you were saying, we did have some headwinds. But if I look across the group, we delivered what we expected to deliver in Q2. ...
Read the full article on Seeking Alpha
For further details see:
Agilent Technologies, Inc. (A) Jefferies 2024 Global Healthcare Conference (Transcript)